Cargando…
Blood Glucose Control in Type 1 Diabetes With a Bihormonal Bionic Endocrine Pancreas
OBJECTIVE: To test whether safe and effective glycemic control could be achieved in type 1 diabetes using a bihormonal bionic endocrine pancreas driven by a continuous glucose monitor in experiments lasting more than two days and including six high-carbohydrate meals and exercise as challenges to gl...
Autores principales: | Russell, Steven J., El-Khatib, Firas H., Nathan, David M., Magyar, Kendra L., Jiang, John, Damiano, Edward R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476884/ https://www.ncbi.nlm.nih.gov/pubmed/22923666 http://dx.doi.org/10.2337/dc12-0071 |
Ejemplares similares
-
The Bihormonal Bionic Pancreas Improves Glycemic Control in Individuals With Hyperinsulinism and Postpancreatectomy Diabetes: A Pilot Study
por: Rayannavar, Arpana, et al.
Publicado: (2021) -
Performance of the Insulin-Only iLet Bionic Pancreas and the Bihormonal iLet Using Dasiglucagon in Adults With Type 1 Diabetes in a Home-Use Setting
por: Castellanos, Luz E., et al.
Publicado: (2021) -
Performance and safety of an integrated bihormonal artificial pancreas for fully automated glucose control at home
por: Blauw, H., et al.
Publicado: (2016) -
Systematically In Silico Comparison of Unihormonal and Bihormonal Artificial Pancreas Systems
por: Gao, Xiaoteng, et al.
Publicado: (2013) -
Improvements in Glycemic Control Achieved by Altering the t(max) Setting in the iLet(®) Bionic Pancreas When Using Fast-Acting Insulin Aspart: A Randomized Trial
por: Russell, Steven J., et al.
Publicado: (2021)